ACCESS Newswire
16 Apr 2019, 19:49 GMT+10
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 16, 2019 / Brighthaven Ventures LLC. ('BHV'), a wholly owned subsidiary of Avolynt, Inc., a company focused on the development of therapeutics for rare and metabolic diseases, announced today the award of over $46 million in judgments against Islet Sciences, Inc. ('Islet') and Islet CEO John F. Steel IV.
In 2015, Islet, formerly a publicly traded company, now delisted, filed civil claims against BHV and two BHV executives. The claims were litigated in the North Carolina Business Court in Raleigh, North Carolina, and all claims brought by Islet were dismissed with prejudice by the Court.
BHV filed counter claims against Islet and third-party claims against John F. Steel IV, Edward T. Gibstein, and COVA Capital Partners, LLC. The Court found Islet, Steel, Gibstein, and COVA liable on the BHV claims and awarded damages to BHV in excess of $46 million on its claims against Islet and Steel. BHV entered into a confidential settlement agreement with Gibstein and COVA, the terms of which were not disclosed.
'Islet's claims were baseless, and we are very pleased that the Court dismissed Islet's claims with prejudice,' said Avolynt CEO James Green. 'The BHV claims for damages were material, and we are pleased with the outcome on those claims as well.'
About Brighthaven Ventures, LLC
Brighthaven Ventures, LLC, d/b/a BHV Pharma is a wholly owned subsidiary of Avolynt Inc.
About Avolynt, Inc.
Avolynt is a privately-owned drug development company based in Research Triangle Park, North Carolina. Avolynt's mission is to improve the lives of patients suffering from dysfunctions related to human metabolism. The Avolynt team has significant discovery and development experience across the metabolic syndrome, including diabetes, obesity, nonalcoholic steatohepatitis (NASH) and other metabolic diseases. Through its subsidiaries, Avolynt is developing multiple novel therapeutics for the treatment of metabolic disease. For more information about Avolynt, visitwww.avolynt.com.
CONTACT:
+1 (919)659-5677[email protected]
SOURCE: Avolynt, Inc.
Get a daily dose of Dallas Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Dallas Sun.
More InformationDOVER, Delaware: California Governor Gavin Newsom has taken legal aim at Fox News, accusing the network of deliberately distorting...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
TORONTO, Canada: Harvard University and the University of Toronto have created a backup plan to ensure Harvard graduate students continue...
JERUSALEM, Israel: Israeli Prime Minister Benjamin Netanyahu says that Israel's success in the war with Iran could open the door to...
NEW DELHI, India: India has decided not to allow a United Nations (UN) investigator to join the investigation into the recent Air India...
BONN, Germany: Despite widespread belt-tightening across the United Nations, nearly 200 countries agreed this week to increase the...
NEW YORK, New York - U.S. stock markets closed firmly in positive territory to start the week Monday, with the S&P 500 and Dow Jones...
WASHINGTON, D.C.: On Friday, President Donald Trump announced that he was halting trade discussions with Canada due to its decision...
LONDON, U.K.: A little-known investment fund based in the United Arab Emirates has emerged as the most prominent public backer of U.S....
SAN FRANCISCO, California: Across the U.S., a growing number of people are taking obesity treatment into their own hands — literally....
SAN FRANCISCO, California: Under pressure from European regulators, Apple has revamped its App Store policies in the EU, introducing...
NEW YORK CITY, New York: The U.S. dollar tumbled this week, hitting its lowest levels since 2021 against the euro, British pound, and...